肿瘤浸润免疫细胞与预后：常规癌症疗法与免疫之间的潜在联系。
Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity.
机构信息
Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Exp Biol Med (Maywood). 2011 May 1;236(5):567-79. doi: 10.1258/ebm.2011.011007. Epub 2011 Apr 12.
Abstract
Numerous studies have now documented a link between the immune infiltrate in several human carcinoma types and prognosis and response to therapy. The most comprehensive of these studies were in colorectal cancer with similar conclusions by numerous groups. Analyses of immune infiltrate of several other carcinoma types also showed general correlations between immune infiltrate and prognosis, but with some conflicting results. This review will attempt to summarize the current state of this field and point out what factors may be responsible for some of the conflicting findings. Nonetheless, the breadth of reports drawing similar conclusions for some cancer cell types leads one to more seriously consider the link between immune cell infiltrate and tumor prognosis and/or response to therapy, and the potential for combining conventional cancer therapy with active immunotherapy employing therapeutic cancer vaccines.
摘要
目前已有大量研究证实，几种人类癌症类型中的免疫浸润与预后和对治疗的反应之间存在关联。其中最全面的研究是在结直肠癌中进行的，许多研究小组得出了类似的结论。对其他几种癌症类型的免疫浸润分析也表明，免疫浸润与预后之间存在普遍相关性，但也存在一些相互矛盾的结果。本综述将尝试总结该领域的现状，并指出哪些因素可能导致部分研究结果存在冲突。尽管如此，对于一些癌症细胞类型，大量报告得出相似结论，这使得人们更加认真地考虑免疫细胞浸润与肿瘤预后和/或对治疗的反应之间的联系，以及将传统癌症治疗与使用治疗性癌症疫苗的主动免疫疗法相结合的可能性。
相似文献
1
Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity.肿瘤浸润免疫细胞与预后：常规癌症疗法与免疫之间的潜在联系。
Exp Biol Med (Maywood). 2011 May 1;236(5):567-79. doi: 10.1258/ebm.2011.011007. Epub 2011 Apr 12.
2
Correlate tumor mutation burden with immune signatures in human cancers.分析人类肿瘤中的肿瘤突变负担与免疫特征的相关性。
BMC Immunol. 2019 Jan 11;20(1):4. doi: 10.1186/s12865-018-0285-5.
3
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?肿瘤浸润淋巴细胞在实体瘤患者中的作用：水滴石穿？
Cell Immunol. 2019 Sep;343:103753. doi: 10.1016/j.cellimm.2018.01.013. Epub 2018 Feb 1.
4
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.肿瘤免疫的综合分析：对癌症免疫治疗的启示
Genome Biol. 2016 Aug 22;17(1):174. doi: 10.1186/s13059-016-1028-7.
5
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.癌症免疫疗法的历史与进展：了解肿瘤浸润免疫细胞的特征及其治疗意义。
Cell Mol Immunol. 2020 Aug;17(8):807-821. doi: 10.1038/s41423-020-0488-6. Epub 2020 Jul 1.
6
Targeting Treg cells in cancer immunotherapy.在癌症免疫治疗中靶向调节性 T 细胞。
Eur J Immunol. 2019 Aug;49(8):1140-1146. doi: 10.1002/eji.201847659. Epub 2019 Jul 5.
7
DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer.基于 DNA 甲基化的 CD8+ 肿瘤浸润淋巴细胞特征可用于评估结直肠癌的免疫反应和预后。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002671.
8
Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment.在T细胞炎症性和非T细胞炎症性肿瘤微环境背景下的肿瘤逃逸机制。
Int Immunol. 2016 Aug;28(8):383-91. doi: 10.1093/intimm/dxw014. Epub 2016 Mar 17.
9
[Immune response and colorectal cancer].[免疫反应与结直肠癌]
Bull Cancer. 2013 Mar;100(3):283-94. doi: 10.1684/bdc.2013.1716.
10
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?肿瘤浸润淋巴细胞在癌症免疫治疗的患者选择中是主角还是配角？
Expert Opin Biol Ther. 2017 Jun;17(6):735-746. doi: 10.1080/14712598.2017.1309387. Epub 2017 Mar 28.
引用本文的文献
1
Diagnosis of cancer, autoimmune and infectious diseases and prediction of the therapy effectiveness based on the individual's immunotype.基于个体免疫类型对癌症、自身免疫性疾病和传染病进行诊断，并预测治疗效果。
Front Immunol. 2025 Aug 29;16:1658970. doi: 10.3389/fimmu.2025.1658970. eCollection 2025.
2
Emerging Understanding of Gut Microbiome in Colorectal Cancer and Food-Related Intervention Strategies.对结直肠癌中肠道微生物群的新认识及与食物相关的干预策略
Foods. 2025 Aug 29;14(17):3040. doi: 10.3390/foods14173040.
3
Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance.解读腺苷脱氨酶作用于RNA（ADARs）在癌症发病机制、肿瘤免疫逃逸和耐药性中的机制性作用。
Front Immunol. 2025 Aug 7;16:1621585. doi: 10.3389/fimmu.2025.1621585. eCollection 2025.
4
Identification and validation of a hypoxia- and immune-related prognostic signature for pancreatic cancer.胰腺癌缺氧和免疫相关预后标志物的鉴定与验证
Biochem Biophys Rep. 2025 Aug 11;43:102205. doi: 10.1016/j.bbrep.2025.102205. eCollection 2025 Sep.
5
Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review.癌症相关成纤维细胞在癌症耐药性和癌症进展中的作用：综述
Cell Death Discov. 2025 Jul 24;11(1):341. doi: 10.1038/s41420-025-02566-x.
6
Precision prognostication in neuroblastomas via clinically validated E2F activity signatures.通过临床验证的E2F活性特征对神经母细胞瘤进行精准预后预测。
Front Immunol. 2025 Jun 17;16:1612667. doi: 10.3389/fimmu.2025.1612667. eCollection 2025.
7
DECEPTICON: a correlation-based strategy for RNA-seq deconvolution inspired by a variation of the Anna Karenina principle.霸天虎：一种基于相关性的RNA测序反卷积策略，灵感源自安娜·卡列尼娜原则的一种变体。
Brief Bioinform. 2025 May 3;26(3). doi: 10.1093/bib/bbaf234.
8
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of hepatocellular carcinoma.血清高尔基体蛋白73（GP73）是肝细胞癌的一种诊断和预后标志物。
Front Med (Lausanne). 2025 Apr 14;12:1571761. doi: 10.3389/fmed.2025.1571761. eCollection 2025.
9
Integrating bioinformatics with experimental validation unveils immunological and prognostic significance of PVRIG in pan-cancer.将生物信息学与实验验证相结合，揭示了PVRIG在泛癌中的免疫学和预后意义。
Sci Rep. 2025 Apr 9;15(1):12095. doi: 10.1038/s41598-025-89308-2.
10
Dynamics of T cell subpopulations and plasma cytokines during the first year of antineoplastic therapy in patients with breast cancer: the BEGYN-1 study.乳腺癌患者抗肿瘤治疗第一年期间T细胞亚群和血浆细胞因子的动态变化：BEGYN-1研究
Breast Cancer Res. 2025 Apr 1;27(1):50. doi: 10.1186/s13058-025-01997-9.
本文引用的文献
1
Epigenetic quantification of tumor-infiltrating T-lymphocytes.肿瘤浸润 T 淋巴细胞的表观遗传学定量分析。
Epigenetics. 2011 Feb;6(2):236-46. doi: 10.4161/epi.6.2.13755. Epub 2011 Feb 1.
2
Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression.巨噬细胞中缺氧诱导因子-1α的表达抑制了 T 细胞的功能并促进了肿瘤的进展。
Cancer Res. 2010 Oct 1;70(19):7465-75. doi: 10.1158/0008-5472.CAN-10-1439. Epub 2010 Sep 14.
3
An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer.评估 FOXP3+浸润细胞在人乳腺癌中的临床意义。
Breast Cancer Res Treat. 2011 May;127(1):99-108. doi: 10.1007/s10549-010-0987-8. Epub 2010 Jun 17.
4
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.调节性（FoxP3+）T 细胞肿瘤浸润是接受化疗或化疗免疫治疗的晚期结肠癌患者的有利预后因素。
J Immunother. 2010 May;33(4):435-41. doi: 10.1097/CJI.0b013e3181d32f01.
5
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.化疗增强了癌症免疫治疗中 CTL 介导的杀伤肿瘤细胞的敏感性。
J Clin Invest. 2010 Apr;120(4):1111-24. doi: 10.1172/JCI40269. Epub 2010 Mar 15.
6
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.原位细胞毒性T细胞和记忆T细胞可预测早期结直肠癌患者的预后。
J Clin Oncol. 2009 Dec 10;27(35):5944-51. doi: 10.1200/JCO.2008.19.6147. Epub 2009 Oct 26.
7
Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.淋巴细胞对结直肠癌的反应与更长的生存时间相关，与淋巴结计数、微卫星不稳定性、CpG 岛甲基化表型无关。
Clin Cancer Res. 2009 Oct 15;15(20):6412-20. doi: 10.1158/1078-0432.CCR-09-1438. Epub 2009 Oct 13.
8
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.癌症抗原的优先级排序：美国国立癌症研究所加速转化研究的试点项目
Clin Cancer Res. 2009 Sep 1;15(17):5323-37. doi: 10.1158/1078-0432.CCR-09-0737.
9
Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.肿瘤内中性粒细胞的存在是局限性肾细胞癌的一个独立预后因素。
J Clin Oncol. 2009 Oct 1;27(28):4709-17. doi: 10.1200/JCO.2008.18.9498. Epub 2009 Aug 31.
10
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts.利用淋巴细胞减少的生理学特性来支持淋巴细胞充足宿主的过继性免疫治疗。
Blood. 2009 Oct 29;114(18):3831-40. doi: 10.1182/blood-2009-03-212134. Epub 2009 Aug 24.
Zotero 插件